1|Page
MGCCC LEVEL 2 NURSING NEURO EXAM
2025/2026; CERTIFIED EXAM QUESTIONS WITH
VERIFIED DETAILED ANSWERS
Medical Management of MG -correct- answer-- Directed at improving function
and reducing and removing circulating antibodies.
- Mestinon, an anticholinesterase medication is the first line of therapy. See chart
64-4 for side effects. Mestinon has fewer side effects than the other meds.
- If Mestinon does not improve muscle strength and control fatigue, the next
agents are used are the immunomodulating drugs. The goal is to decrease
production of the antibodies (steriods;ie Prednisone)
- Plasmapheresis- plasma exchange produces a temporary reduction in the level
of circulating antibodies; it lasts for a few weeks and it is a technique used to treat
exacerbations.
- Surgical Management that includes a thymectomy (removal of the thymus
gland). It can produce antigen-specific immunosuppression and result in clinical
improvement. Post-op (ICU) watch for respiratory complications. It might take up
to 3 years before seeing improvement due to the long life of circulating T cells.
Crisis in MG -correct- answer-Myasthenic :
- Result of disease exacerbation or a precipitating event, most commonly a
respiratory infection
- Severe generalized muscle weakness with respiratory and bulbar weakness
- Patient may develop respiratory failure
,2|Page
Cholinergic:
- Caused by overmedication w/ cholinesterase inhibitors
- Severe muscle weakness with respiratory and bulbar weakness
- Patient may develop respiratory compromise and failure
- Atropine on standby
Nursing Process—Myasthenia Gravis -correct- answer-- Focus on patient and
family teaching
- Provide medication teaching and management
- Implement energy conservation measures
- Implement strategies to help with ocular manifestations
- Prevent and/or manage complications and avoid crisis
- Implement measures to reduce risk of aspiration
- Avoid stress, infections, vigorous physical activity, some medications, and high
environmental temperatures
Degenerative Disk Disease -correct- answer-- Low back pain is a significant public
health disorder
- Acute low back pain lasts less than 3 months
- Degenerative disk disease has a duration of 3 months or longer
- Herniation of a disk = ruptured disk
- MRI (diagnostic tool of choice)
, 3|Page
- Medical Management: bed rest & medication
Medical Management of DDD -correct- answer-Most managed conservatively
- Bedrest
- Brace
- Medications
Neuropathic
Pain
Muscle
Surgical Intervention of DDD -correct- answer-- Progressing neuro deficit
- Sciatic pain unresponsive to conservative mgt.
- GOAL: reduce pressure on nerve root and reverse neurologic deficits
Neurotransmitters -correct- answer-Communicate messages from one neuron to
another or to a specific target range.
**Potentiate
**Terminate
**Modulates
MGCCC LEVEL 2 NURSING NEURO EXAM
2025/2026; CERTIFIED EXAM QUESTIONS WITH
VERIFIED DETAILED ANSWERS
Medical Management of MG -correct- answer-- Directed at improving function
and reducing and removing circulating antibodies.
- Mestinon, an anticholinesterase medication is the first line of therapy. See chart
64-4 for side effects. Mestinon has fewer side effects than the other meds.
- If Mestinon does not improve muscle strength and control fatigue, the next
agents are used are the immunomodulating drugs. The goal is to decrease
production of the antibodies (steriods;ie Prednisone)
- Plasmapheresis- plasma exchange produces a temporary reduction in the level
of circulating antibodies; it lasts for a few weeks and it is a technique used to treat
exacerbations.
- Surgical Management that includes a thymectomy (removal of the thymus
gland). It can produce antigen-specific immunosuppression and result in clinical
improvement. Post-op (ICU) watch for respiratory complications. It might take up
to 3 years before seeing improvement due to the long life of circulating T cells.
Crisis in MG -correct- answer-Myasthenic :
- Result of disease exacerbation or a precipitating event, most commonly a
respiratory infection
- Severe generalized muscle weakness with respiratory and bulbar weakness
- Patient may develop respiratory failure
,2|Page
Cholinergic:
- Caused by overmedication w/ cholinesterase inhibitors
- Severe muscle weakness with respiratory and bulbar weakness
- Patient may develop respiratory compromise and failure
- Atropine on standby
Nursing Process—Myasthenia Gravis -correct- answer-- Focus on patient and
family teaching
- Provide medication teaching and management
- Implement energy conservation measures
- Implement strategies to help with ocular manifestations
- Prevent and/or manage complications and avoid crisis
- Implement measures to reduce risk of aspiration
- Avoid stress, infections, vigorous physical activity, some medications, and high
environmental temperatures
Degenerative Disk Disease -correct- answer-- Low back pain is a significant public
health disorder
- Acute low back pain lasts less than 3 months
- Degenerative disk disease has a duration of 3 months or longer
- Herniation of a disk = ruptured disk
- MRI (diagnostic tool of choice)
, 3|Page
- Medical Management: bed rest & medication
Medical Management of DDD -correct- answer-Most managed conservatively
- Bedrest
- Brace
- Medications
Neuropathic
Pain
Muscle
Surgical Intervention of DDD -correct- answer-- Progressing neuro deficit
- Sciatic pain unresponsive to conservative mgt.
- GOAL: reduce pressure on nerve root and reverse neurologic deficits
Neurotransmitters -correct- answer-Communicate messages from one neuron to
another or to a specific target range.
**Potentiate
**Terminate
**Modulates
